Allergy Immunotherapy Market Size, Trends, and Forecast Till 2028

Comments ยท 2 Views

The global allergy immunotherapy market size was valued at USD 1.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% during the forecast period 2021-2028.

 

Allergy Immunotherapy Market Size, Share & Trends Analysis Report, By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel, and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Allergy Immunotherapy Market Overview

The global allergy immunotherapy market size was valued at USD 1.6 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% during the forecast period 2021-2028.

Allergy immunotherapy is used for the treatment of allergic asthma, allergic rhinitis/conjunctivitis, and stringent insect hypersensitivity.

The rising prevalence of allergic disorders and their burden across the globe and Complex allergies with higher morbidity serve as a burden on the healthcare system are some of the factors that have supported long-term expansion for Allergy Immunotherapy Market.

Get a Sample Copy of the Allergy Immunotherapy Market Research Report: https://www.delvens.com/get-free-sample/allergy-immunotherapy-market

The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. It is expected that the allergy immunotherapy market in the global market will recover from this global pandemic situation by the end of the second quarter and the beginning of the third quarter in the coming year during the forecasted period from 2017 to 2023.

Allergy Immunotherapy Market Regional Analysis

Europe accounted for the largest share of 69.1% in 2019 and is expected to hold its position throughout the forecast period. However, Asia Pacific is projected to register the fastest CAGR throughout the forecast period.

Allergy Immunotherapy Market Competitive Landscape

Key Players

  • ASIT Biotech
  • Circassia
  • Mylan N.V.
  • Adamis Pharmaceuticals Corporation
  • Merck KGaA, Stallergenes Greer plc
  • Allergy Therapeutics
  • ALK-Abelló A/S
  • DESENTUM OY
  • HAL Allergy B.V.
  • HollisterStier Allergy
  • LETIPharma
  • DBV Technologies SA.

Inquire before you purchase to increase your business' revenue: https://www.delvens.com/Inquire-before-buying/allergy-immunotherapy-market

Allergy Immunotherapy Market Recent Developments

  • ALK Abello A/S took off the working assets allergy laboratory in Oklahoma Incand crystal labs in January 2017.
  •  Stallergenes S.A and DVB Technologies entered into a research agreement with Stallergenes S.A. for the birch allergy treatment in October 2017.

Reasons to Acquire in the Allergy Immunotherapy Market

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Allergy Immunotherapy Market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Direct Purchase of Allergy Immunotherapy Market Research Report: https://www.delvens.com/checkout/allergy-immunotherapy-market

Frequently Asked Questions

What are the years considered to study Allergy Immunotherapy Market?

What is the compound annual growth rate (CAGR) of the Allergy Immunotherapy Market?

Which region holds the largest market share in Allergy Immunotherapy Market?

Who are the major players in Allergy Immunotherapy Market?

Browse Related Reports:

Pendred Syndrome (PS) Market – Trends Forecast Till 2030

Pendred Syndrome (PS) Market by Treatment (Cochlear Implant, Hearing Aids, and Radioactive Iodine) Route of Administration (Oral, Implantation), Diagnosis (Genetic Testing, Perchlorate Washout Test, and Others), End- Users (Hospitals, Homecare, Specialty Clinics, Otolaryngologist, and Others) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

Pain Relief Gel Market – Trends Forecast Till 2030

Global Pain Relief Gel Market, By Therapeutic Class (Non-Opioids, Opioids), Type (Prescription Pain Relief, Over-the-Counter Pain Relief), Distribution Channel (Pharmacies & Drug Stores, e-Commerce, Retail & Grocery Stores) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).

About Us:

Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.

Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.

Contact Us:

UNIT NO. 2126, TOWER B,

21ST FLOOR ALPHATHUM

SECTOR 90 NOIDA 201305, IN

+44-20-8638-5055

SALES@DELVENS.COM

Comments